X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51) 51
humans (47) 47
dermatology (30) 30
vitiligo (16) 16
male (15) 15
adult (14) 14
female (14) 14
skin (14) 14
melanoma (13) 13
middle aged (13) 13
animals (12) 12
oncology (11) 11
cell biology (9) 9
medical laboratory technology (9) 9
vitiligo - pathology (9) 9
analysis (8) 8
genetic aspects (7) 7
medicine and health sciences (7) 7
cancer (6) 6
care and treatment (6) 6
diagnosis (6) 6
immunology (6) 6
proteins (6) 6
psoriasis (6) 6
research (6) 6
t-cells (6) 6
expression (5) 5
haptoglobin (5) 5
integumentary system (5) 5
melanoma - immunology (5) 5
mice (5) 5
oxidative stress (5) 5
phenotype (5) 5
polymorphism (5) 5
polymorphism, genetic (5) 5
regulatory t-cells (5) 5
skin diseases (5) 5
young adult (5) 5
adolescent (4) 4
aged (4) 4
biomarkers (4) 4
clinical trials (4) 4
generalized vitiligo (4) 4
genetic polymorphism (4) 4
group-specific component (4) 4
haptoglobins - genetics (4) 4
health aspects (4) 4
human melanocytes (4) 4
immunotherapy (4) 4
inflammation (4) 4
medicine (4) 4
melanocyte (4) 4
metastasis (4) 4
pathogenesis (4) 4
signal transduction (4) 4
t cells (4) 4
treatment outcome (4) 4
tumors (4) 4
vitamin d (4) 4
vitiligo - diagnosis (4) 4
vitiligo - drug therapy (4) 4
vitiligo - immunology (4) 4
vitiligo - metabolism (4) 4
vitiligo - therapy (4) 4
administration, cutaneous (3) 3
biochemistry, genetics and molecular biology (3) 3
biological markers (3) 3
biomarkers - blood (3) 3
biomarkers - metabolism (3) 3
cells (3) 3
child (3) 3
cosmin (3) 3
dendritic cells (3) 3
depigmentation (3) 3
disease-activity (3) 3
double-blind (3) 3
enzymes (3) 3
genetic predisposition to disease (3) 3
immune response (3) 3
immune system (3) 3
in-vitro (3) 3
indoleamine 2,3-dioxygenase (3) 3
kidney diseases - metabolism (3) 3
lymphocytes (3) 3
malignant-melanoma (3) 3
medical colleges (3) 3
medical research (3) 3
medicine & public health (3) 3
melanocytes (3) 3
melanocytes - metabolism (3) 3
melanoma - pathology (3) 3
observer variation (3) 3
patients (3) 3
prognosis (3) 3
review (3) 3
risk factors (3) 3
severity of illness index (3) 3
skin - metabolism (3) 3
skin neoplasms - immunology (3) 3
skin neoplasms - pathology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Dermatologic Clinics, ISSN 0733-8635, 04/2017, Volume 35, Issue 2, pp. 145 - 150
Segmental vitiligo is characterized by its early onset, rapid stabilization, and unilateral distribution. Recent evidence suggests that segmental and... 
Vitiligo | Segmental | Surgical treatment | Classification | Mosaicism | Halo nevi | Lines of blaschko | Segmental vitiligo | CLUES | FACE | DERMATOLOGY | Vitiligo - classification | Vitiligo - diagnosis | Vitiligo - pathology | Humans | Skin - pathology
Journal Article
Critical reviews in clinical laboratory sciences, 05/2019, p. 1
Initially considered as a macrophage inhibitor (macrophage inhibitory cytokine-1), growth differentiation factor 15 (GDF-15) has been identified as a... 
Journal Article
OncoImmunology, ISSN 2162-4011, 07/2012, Volume 1, Issue 4, pp. 526 - 528
Insights into immune reactions against benign and malignant melanocytes may help the development of more efficient immunotherapeutic treatments for melanoma.... 
melanoma | haptenation | melanocyte | immunosurveillance | regression | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Regression | Haptenation | Immunosurveillance | Melanocyte | Melanoma | ONCOLOGY | VITILIGO | IMMUNOLOGY | NEVI | Author's View
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0164080
The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK... 
SIGNAL-TRANSDUCTION | ATOPIC-DERMATITIS | LICHEN-PLANUS | PATHWAY | MULTIDISCIPLINARY SCIENCES | THERAPEUTIC TARGET | STAT3 | KERATINOCYTES | EXPRESSION | PSORIASIS | KINASE INHIBITOR TOFACITINIB | Gene Expression Regulation, Enzymologic - drug effects | Skin - metabolism | Humans | Middle Aged | STAT Transcription Factors - metabolism | Child, Preschool | Infant | Male | Molecular Targeted Therapy | Janus Kinase 3 - antagonists & inhibitors | Young Adult | Inflammation - complications | Aged, 80 and over | Adult | Female | Janus Kinase 3 - metabolism | Child | Skin - pathology | Skin Diseases - drug therapy | Protein Kinase Inhibitors - administration & dosage | STAT Transcription Factors - genetics | Skin Diseases - complications | Protein Kinase Inhibitors - therapeutic use | Adolescent | Janus Kinase 3 - genetics | Aged | Protein Kinase Inhibitors - pharmacology | Skin Diseases - enzymology | Administration, Topical | Skin - drug effects | Care and treatment | Psoriasis | Atopic dermatitis | Dermatology | Formulae, receipts, prescriptions | Dermatologic agents | Skin | Tyk2 protein | Phosphorylation | Lichen planus | Kinases | Dermatitis | Inflammatory diseases | Signal transduction | Rodents | Janus kinase 2 | Skin diseases | Janus kinase | Immune system | Formulations | Lupus | Cytokines | Baldness | Medical treatment | Feasibility studies | Keratinocytes | Epidermis | Gene expression | Diseases | Signaling | Chronic conditions | Inhibitors | Alopecia | Pyoderma | Biopsy | Cutaneous Lupus Erythematosus | Autoimmune diseases | Pyoderma gangrenosum
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2014, Volume 14, Issue 4, pp. 332 - 340
Abstract Vitiligo is a recalcitrant depigmentary skin disorder with significant effects on the quality of life and a frequent association with other autoimmune... 
Allergy and Immunology | Vitiligo | Treatment | Pathogenesis | Autoinflammatory | OXIDATIVE STRESS | IMMUNOHISTOCHEMICAL EXPRESSION | BAND-ULTRAVIOLET-B | IMMUNOLOGY | REPIGMENTATION | IMMUNE-RESPONSES | INFLAMMATION | INCREASED SENSITIVITY | REGULATORY T-CELLS | TACROLIMUS | MELANOCYTE
Journal Article